LFA
CVS icon

Landmark Financial Advisors’s CVS Health CVS Stock Holding History

Landmark Financial Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$329K Buy
4,166
+153
+4% +$10.9K 0.12% 71
2023
Q3 		$280K Buy
4,013
+127
+3% +$9K 0.11% 75
2023
Q2 		$269K Sell
3,886
-220
-5% -$15.7K 0.11% 77
2023
Q1 		$305K Buy
4,106
+113
+3% +$9.48K 0.13% 70
2022
Q4 		$372K Buy
3,993
+155
+4% +$15K 0.17% 65
2022
Q3 		$366K Buy
3,838
+60
+2% +$5.94K 0.19% 60
2022
Q2 		$350K Sell
3,778
-20
-0.5% -$1.95K 0.17% 62
2022
Q1 		$387K Buy
3,798
+100
+3% +$10.5K 0.19% 60
2021
Q4 		$381K Buy
3,698
+351
+10% +$32.4K 0.17% 62
2021
Q3 		$252K Sell
3,347
-145
-4% -$12.1K 0.14% 62
2021
Q2 		$291K Buy
3,492
+145
+4% +$11.9K 0.14% 64
2021
Q1 		$252K Buy
3,347
+170
+5% +$12.4K 0.14% 62
2020
Q4 		$242K Buy
+3,177
New +$207K 0.14% 62

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Landmark Financial Advisors's CVS Position: Q4 2023 in Review

Landmark Financial Advisors increased its CVS Health (CVS) stake by 3.8% in Q4 2023, buying an estimated $10.9K and bringing the position to 4,166 shares worth $329K. The position accounts for 0.12% of the portfolio, ranked #71.

Landmark Financial Advisors first reported a position in CVS in Q4 2020 and has held it in 13 quarters since. The position peaked at $387K in Q1 2022. 2,263 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Landmark Financial Advisors held 4,166 shares of CVS Health worth $329K as of Q4 2023.
  • Landmark Financial Advisors bought 153 CVS Health shares in Q4 2023, an estimated $10.9K.
  • CVS Health made up 0.12% of Landmark Financial Advisors's portfolio in Q4 2023, its #71 holding.
  • Landmark Financial Advisors first reported a position in CVS Health in Q4 2020 and has held it in 13 quarters since.
  • Landmark Financial Advisors's CVS Health position peaked at $387K in Q1 2022.
  • 2,263 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Landmark Financial Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.